The acquired immunodeficiency syndrome disease, abbreviated AIDS, is caused by the retrovirus, human immunodeficiency virus subtype1 (HIV‐1). Infection with the virus leads to severe suppression of the immune system and potential exposure to the so‐called opportunistic infections such as pneumonia, which could be fatal. Most of the currently available anti‐AIDS medications are inhibitors for the reverse transcriptase and protease enzymes. The growing resistance to the currently available drugs requires developing new agents that act by different mechanisms beyond transcriptase and protease inhibition. Treatment of AIDS and development of anti‐HIV agents to stop the virus replication requires acquaintance with various steps of the virus life cycle and the mechanism of how it reproduces itself. The present chapter describes the molecular aspects of the AIDS virus including its structure, molecular biology, and life cycle. Approaches to design anti‐HIV drugs are presented with update on the status of anti‐HIV therapeutic agents in the light of the continuous growing viral mutation.